Exhibit 99.1
@coherent | | PRESS RELEASE |
Editorial Contact: | | For Release: |
Leen Simonet | | IMMEDIATE |
(408) 764-4110 | | April 24, 2013 |
| | No. 1358 |
Coherent, Inc. Reports Second Fiscal Quarter Results
SANTA CLARA, CA, April 24, 2013 — Coherent, Inc. (NASDAQ, COHR), a world leader in providing photonics based solutions to the commercial and scientific research markets, today announced financial results for its second fiscal quarter ended March 30, 2013.
FINANCIAL HIGHLIGHTS
| | Three Months Ended | | Six Months Ended | |
| | March 30, | | Dec. 29, | | March 31, | | March 30, | | March 31, | |
| | 2013 | | 2012 | | 2012 | | 2013 | | 2012 | |
GAAP Results | | | | | | | | | | | |
(in millions except per share data) | | | | | | | | | | | |
Bookings | | $ | 201.8 | | $ | 176.0 | | $ | 183.1 | | $ | 377.8 | | $ | 385.0 | |
Net sales | | $ | 200.1 | | $ | 183.2 | | $ | 193.3 | | $ | 383.3 | | $ | 384.1 | |
Net income | | $ | 15.0 | | $ | 14.2 | | $ | 16.2 | | $ | 29.2 | | $ | 33.2 | |
Diluted EPS | | $ | 0.61 | | $ | 0.58 | | $ | 0.67 | | $ | 1.20 | | $ | 1.38 | |
| | | | | | | | | | | |
Non-GAAP Results | | | | | | | | | | | |
(in millions except per share data) | | | | | | | | | | | |
Net income | | $ | 20.7 | | $ | 18.6 | | $ | 18.6 | | $ | 39.3 | | $ | 39.4 | |
Diluted EPS | | $ | 0.84 | | $ | 0.77 | | $ | 0.77 | | $ | 1.61 | | $ | 1.64 | |
SECOND FISCAL QUARTER DETAILS
For the second fiscal quarter ended March 30, 2013, Coherent announced net sales of $200.1 million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $15.0 million, or $0.61 per diluted share. These results compare to net sales of $193.3 million and net income of $16.2 million, or $0.67 per diluted share, for the second quarter of fiscal 2012. Non-GAAP net income for the second quarter of fiscal 2013 was $20.7 million, or $0.84 per diluted share. Non-GAAP net income for the second quarter of fiscal 2012 was $18.6 million, or $0.77 per diluted share. We have revised our presentation of non-GAAP net income and non-GAAP diluted EPS for all periods presented to exclude the effect of intangibles amortization and inventory step up costs. For a complete overview of the differences between GAAP and non-GAAP results, please see the reconciliation table included at the end of our release.
Net sales for the first quarter of fiscal 2013 were $183.2 million and net income, on a GAAP basis, was $14.2 million, or $0.58 per diluted share. Non-GAAP net income for the first quarter of fiscal 2013 was $18.6 million, or $0.77 per diluted share.
Bookings received during the second fiscal quarter ended March 30, 2013 of $201.8 million increased 10.2% from $183.1 million in the same prior year period and increased by 14.7% compared to bookings of $176.0 million in the immediately preceding quarter. The book-to-bill ratio was 1.01, resulting in backlog of $333.0 million at March 30, 2013, compared to a backlog of $348.1 million at December 29, 2012 and a backlog of $349.2 million at March 31, 2012.
“Demand improved across many of our commercial end markets. We posted record bookings for materials processing including our first volume order for the Highlight™ 1000FL fiber laser for flatbed cutting, strong orders for the Highlight™ D-Series direct diode system for additive manufacturing and several orders for Diamond™ E-1000 lasers to be used in converting. The advanced packaging (API) market continued to build momentum with orders rising sequentially and year-over-year due to rising demand for any layer HDI PCBs for mobile devices and high-end IC substrates. Orders also picked up in the semicap market as utilization rates rose and end users increased their service needs and expanded capacity for advanced nodes. Bookings for medical OEM applications were at an all-time high and benefitted from our recent acquisition of Lumera Laser. The only market to exhibit softness was the research market where stronger demand in Asia could not overcome the effects of sequestration in the U.S. and belt tightening in Europe,” said John Ambroseo, Coherent’s President and Chief Executive Officer.
Coherent ended the quarter with cash, cash equivalents and short term investments of $204.0 million, an increase of $24.2 million from cash, cash equivalents and short term investments of $179.8 million at December 29, 2012.
CONFERENCE CALL REMINDER
The Company will host a conference call today to discuss its financial results at 1:30 P.M. Pacific (4:30 P.M. Eastern). A listen-only broadcast of the conference call can be accessed on the Company’s website at either http://www.coherent.com/Investors/ or http://www.earnings.com. For those who are not able to listen to the live broadcast, the call will be archived for approximately three months on both web sites. A transcript of management’s prepared remarks can be found at http://www.coherent.com/Investors/.
Summarized statement of operations information is as follows (unaudited, in thousands except per share data):
| | Three Months Ended | | Six Months Ended | |
| | March 30, | | Dec. 29, | | March 31, | | March 30, | | March 31, | |
| | 2013 | | 2012 | | 2012 | | 2013 | | 2012 | |
| | | | | | | | | | | |
Net sales | | $ | 200,058 | | $ | 183,202 | | $ | 193,284 | | $ | 383,260 | | $ | 384,051 | |
Cost of sales (A) (B) (C) (D) | | 123,727 | | 105,567 | | 115,636 | | 229,294 | | 226,044 | |
Gross profit | | 76,331 | | 77,635 | | 77,648 | | 153,966 | | 158,007 | |
Operating expenses: | | | | | | | | | | | |
Research & development (A) (B) | | 20,146 | | 19,301 | | 20,323 | | 39,447 | | 39,102 | |
Selling, general & administrative (A) (B) | | 37,346 | | 36,982 | | 35,377 | | 74,328 | | 70,008 | |
Intangibles amortization (C) | | 1,942 | | 854 | | 1,611 | | 2,796 | | 3,247 | |
Total operating expenses | | 59,434 | | 57,137 | | 57,311 | | 116,571 | | 112,357 | |
Income from operations | | 16,897 | | 20,498 | | 20,337 | | 37,395 | | 45,650 | |
Other income (expense), net(B) | | 1,295 | | (1,437 | ) | 1,912 | | (142 | ) | 2,430 | |
Income before income taxes | | 18,192 | | 19,061 | | 22,249 | | 37,253 | | 48,080 | |
Provision for income taxes(E) | | 3,190 | | 4,908 | | 6,094 | | 8,098 | | 14,874 | |
Net income | | $ | 15,002 | | $ | 14,153 | | $ | 16,155 | | $ | 29,155 | | $ | 33,206 | |
| | | | | | | | | | | |
Net income per share: | | | | | | | | | | | |
Basic | | $ | 0.62 | | $ | 0.60 | | $ | 0.69 | | $ | 1.22 | | $ | 1.41 | |
Diluted | | $ | 0.61 | | $ | 0.58 | | $ | 0.67 | | $ | 1.20 | | $ | 1.38 | |
| | | | | | | | | | | |
Shares used in computation: | | | | | | | | | | | |
Basic | | 24,085 | | 23,770 | | 23,521 | | 23,928 | | 23,491 | |
Diluted | | 24,475 | | 24,222 | | 23,996 | | 24,348 | | 23,979 | |
(A) Stock-related compensation expense included in operating results is summarized below (all footnote amounts are unaudited, in thousands, except per share data):
Stock-related compensation expense
| | Three Months Ended | | Six Months Ended | |
| | Mar. 30, | | Dec. 29, | | Mar. 31, | | Mar. 30, | | Mar. 31, | |
| | 2013 | | 2012 | | 2012 | | 2013 | | 2012 | |
Cost of sales | | $ | 594 | | $ | 435 | | $ | 441 | | $ | 1,029 | | $ | 810 | |
Research & development | | 467 | | 476 | | 431 | | 943 | | 824 | |
Selling, general & administrative | | 3,581 | | 4,083 | | 3,288 | | 7,664 | | 6,548 | |
Impact on income from operations | | $ | 4,642 | | $ | 4,994 | | $ | 4,160 | | $ | 9,636 | | $ | 8,182 | |
For the quarters ended March 30, 2013, December 29, 2012, and March 31, 2012, the impact on net income, net of tax was $3,497 ($0.14 per diluted share), $3,511 ($0.14 per diluted share) and $2,895 ($0.12 per diluted share), respectively. For the six months ended March 30, 2013 and March 31, 2012, the impact on net income, net of tax was $7,008 ($0.29 per diluted share) and $5,589 ($0.23 per diluted share), respectively.
(B) Changes in deferred compensation plan liabilities are included in cost of sales and operating expenses while gains and losses on deferred compensation plan assets are included in other income (expense) net. Deferred compensation expense (benefit) included in operating results is summarized below:
Deferred compensation expense (benefit)
| | Three Months Ended | | Six Months Ended | |
| | Mar. 30, | | Dec. 29, | | Mar. 31, | | Mar. 30, | | Mar. 31, | |
| | 2013 | | 2012 | | 2012 | | 2013 | | 2012 | |
Cost of sales | | $ | 37 | | $ | 14 | | $ | 46 | | $ | 51 | | $ | 50 | |
Research & development | | 149 | | 62 | | 213 | | 211 | | 232 | |
Selling, general & administrative | | 1,066 | | 426 | | 1,439 | | 1,492 | | 1,555 | |
Impact on income from operations | | $ | 1,252 | | $ | 502 | | $ | 1,698 | | $ | 1,754 | | $ | 1,837 | |
For the quarters ended March 30, 2013, December 29, 2012 and March 31, 2012, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was income of $983, income of $294 and income of $1,541, respectively. For the six months ended March 30, 2013 and March 31, 2012, the impact on other income (expense) net was income of $1,277 and income of $1,487, respectively.
(C) For the three and six months ended March 30, 2013, the impact of amortization of intangibles expense was $3,408 ($2,775 net of tax ($0.11 per diluted share)) and $4,589 ($3,642 net of tax ($0.15 per diluted share)), respectively. For the three and six months ended March 31, 2012, the impact of amortization of intangibles expense was $1,611 ($1,162 net of tax ($0.05 per diluted share)) and $3,247 ($2,244 net of tax ($0.09 per diluted share)), respectively.
(D) For the three and six months ended March 30, 2013, the impact on net income of our inventory step up costs related to our recent acquisitions, was $1,130 ($791 net of tax ($0.03 per diluted share)) and $1,222 ($855 net of tax ($0.04 per diluted share)), respectively.
(E) The three and six months ended March 30, 2013 included $1,398 ($0.06 per diluted share) benefit from the renewal of the R&D tax credit for fiscal 2012. The three and six months ended March 31, 2012 included $1,647 ($0.07 per diluted share) release of tax reserves and related interest as a result of the closure of open tax years.
Summarized balance sheet information is as follows (unaudited, in thousands):
| | March 30,
2013 | | September 29,
2012 | |
ASSETS | | | | | |
Current assets: | | | | | |
Cash, cash equivalents and short-term investments | | $ | 203,990 | | $ | 224,929 | |
Accounts receivable, net | | 134,479 | | 144,345 | |
Inventories | | 166,865 | | 160,113 | |
Prepaid expenses and other assets | | 80,765 | | 85,098 | |
Total current assets | | 586,099 | | 614,485 | |
Property and equipment, net | | 114,368 | | 115,096 | |
Other assets | | 222,896 | | 151,191 | |
Total assets | | $ | 923,363 | | $ | 880,772 | |
| | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | |
Current liabilities: | | | | | |
Current portion of long-term obligations | | $ | 11 | | $ | 17 | |
Accounts payable | | 39,443 | | 29,088 | |
Other current liabilities | | 131,970 | | 124,683 | |
Total current liabilities | | 171,424 | | 153,788 | |
Other long-term liabilities | | 64,663 | | 55,328 | |
Total stockholders’ equity | | 687,276 | | 671,656 | |
Total liabilities and stockholders’ equity | | $ | 923,363 | | $ | 880,772 | |
Reconciliation of GAAP to Non-GAAP net income (unaudited, in thousands, net of tax):
| | Three Months Ended | | Six Months Ended | |
| | Mar. 30,
2013 | | Dec. 29,
2012 | | Mar. 31,
2012 | | Mar. 30,
2013 | | Mar. 31,
2012 | |
GAAP net income | | $ | 15,002 | | $ | 14,153 | | $ | 16,155 | | $ | 29,155 | | $ | 33,206 | |
Stock-related compensation expense | | 3,497 | | 3,511 | | 2,895 | | 7,008 | | 5,589 | |
Intangibles amortization | | 2,775 | | 867 | | 1,162 | | 3,642 | | 2,244 | |
Inventory step-up | | 791 | | 64 | | — | | 855 | | — | |
Non-recurring tax expense (release) items | | (1,398 | ) | — | | (1,647 | ) | (1,398 | ) | (1,647 | ) |
Non-GAAP net income | | $ | 20,667 | | $ | 18,595 | | $ | 18,565 | | $ | 39,262 | | $ | 39,392 | |
| | | | | | | | | | | |
Non-GAAP net income per diluted share | | $ | 0.84 | | $ | 0.77 | | $ | 0.77 | | $ | 1.61 | | $ | 1.64 | |
Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Standard & Poor’s SmallCap 600 Index and the Russell 2000. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4110. For more information about Coherent, visit the Company’s Web site at http://www.coherent.com/ for product and financial updates.
